Search research articles
Contact Us
Filters
Showing results (211-220 of 241) with videos related to
Page
of 25
Sort By:
Cancer
|
November 16, 2020
Long-term outcomes of pexidartinib in tenosynovial giant cell tumors
Hans Gelderblom, Andrew J Wagner, William D Tap, et al.
Annals of Surgical Oncology
|
May 25, 2016
Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group
Najat C Daw, Nadia N Laack, Elizabeth J McIlvaine, et al.
Future Oncology (London, England)
|
January 18, 2022
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden
Charles Peterfy, Yan Chen, Peter Countryman, et al.
BMC Cancer
|
May 23, 2015
How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations
Andrea Piccioli, M Silvia Spinelli, Jonathan A Forsberg, et al.
Cancer Research
|
March 9, 2005
An expression signature classifies chemotherapy-resistant pediatric osteosarcoma
Michelle B Mintz, Rebecca Sowers, Kevin M Brown, et al.
Cancer Immunology Research
|
July 3, 2024
Augmenting CAR T-cell Functions with LIGHT
Winson Cai, Kento Tanaka, Xiaoli Mi, et al.
Genes & Development
|
September 26, 2013
Induction of sarcomas by mutant IDH2
Chao Lu, Sriram Venneti, Altuna Akalin, et al.
Cancer
|
September 25, 2014
Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group
Steven G DuBois, Mark D Krailo, Mark C Gebhardt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 7, 2019
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma
Marilyn Heng, Abha Gupta, Peter W Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group
Paul A Meyers, Cindy L Schwartz, Mark D Krailo, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 241) with videos related to
Sort By:
Page
of 25
Cancer
|
November 16, 2020
Long-term outcomes of pexidartinib in tenosynovial giant cell tumors
Hans Gelderblom, Andrew J Wagner, William D Tap, et al.
Annals of Surgical Oncology
|
May 25, 2016
Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group
Najat C Daw, Nadia N Laack, Elizabeth J McIlvaine, et al.
Future Oncology (London, England)
|
January 18, 2022
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden
Charles Peterfy, Yan Chen, Peter Countryman, et al.
BMC Cancer
|
May 23, 2015
How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations
Andrea Piccioli, M Silvia Spinelli, Jonathan A Forsberg, et al.
Cancer Research
|
March 9, 2005
An expression signature classifies chemotherapy-resistant pediatric osteosarcoma
Michelle B Mintz, Rebecca Sowers, Kevin M Brown, et al.
Cancer Immunology Research
|
July 3, 2024
Augmenting CAR T-cell Functions with LIGHT
Winson Cai, Kento Tanaka, Xiaoli Mi, et al.
Genes & Development
|
September 26, 2013
Induction of sarcomas by mutant IDH2
Chao Lu, Sriram Venneti, Altuna Akalin, et al.
Cancer
|
September 25, 2014
Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group
Steven G DuBois, Mark D Krailo, Mark C Gebhardt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 7, 2019
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma
Marilyn Heng, Abha Gupta, Peter W Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group
Paul A Meyers, Cindy L Schwartz, Mark D Krailo, et al.
Page
of 25